Avalon GloboCare Corp. Files 8-K
Ticker: ALBT · Form: 8-K · Filed: Apr 1, 2025 · CIK: 1630212
Sentiment: neutral
Topics: disclosure, financial-statements
TL;DR
Avalon GloboCare Corp. filed an 8-K on April 1, 2025, for disclosures and exhibits.
AI Summary
Avalon GloboCare Corp. filed an 8-K on April 1, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, incorporated in Delaware, is involved in Biological Products (No Diagnostic Substances) and has its principal executive offices in Freehold, NJ.
Why It Matters
This filing indicates Avalon GloboCare Corp. is providing updated disclosures and financial information to the SEC, which could be relevant for investors monitoring the company's regulatory compliance and financial health.
Risk Assessment
Risk Level: low — This filing is a routine disclosure and does not appear to contain significant negative or positive news that would immediately impact risk.
Key Players & Entities
- Avalon GloboCare Corp. (company) — Registrant
- April 1, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Freehold, NJ (location) — Address of principal executive offices
FAQ
What is the primary business of Avalon GloboCare Corp.?
Avalon GloboCare Corp. is involved in Biological Products (No Diagnostic Substances).
When was the earliest event reported in this 8-K filing?
The earliest event reported was on April 1, 2025.
In which state is Avalon GloboCare Corp. incorporated?
Avalon GloboCare Corp. is incorporated in Delaware.
What is the address of Avalon GloboCare Corp.'s principal executive offices?
The address is 4400 Route 9 South, Suite 3100, Freehold, NJ 07728.
What type of SEC filing is this?
This is a Form 8-K, a Current Report.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 1, 2025 regarding Avalon GloboCare Corp. (ALBT).